View in EDS

Barriers to Accessing Opioid Treatment in Rural Queensland: Perspectives From Consumers and Clinicians.

Saved in:
Bibliographic Details
Title: Barriers to Accessing Opioid Treatment in Rural Queensland: Perspectives From Consumers and Clinicians.
Authors: Wang, Grace Y. (AUTHOR), Spencer, Daniel (AUTHOR), Thompson, Chelsea (AUTHOR), Fernando, Thilakshi (AUTHOR), O'Brien, Maxine (AUTHOR), Pascoe, Allan (AUTHOR)
Source: Drug & Alcohol Review. Jan2026, Vol. 45 Issue 1, p1-10. 10p.
Subjects: Opioids, Health services accessibility, Telemedicine, Opioid abuse, Stakeholder analysis, Patients' attitudes, Rural geography, Health policy
Geographic Terms: Queensland, Australia
Abstract: Introduction: Opioid treatment (OT) is highly effective for managing opioid use disorder (OUD) but remains underutilised worldwide, including in Australia. This issue is especially pronounced in regional and rural areas; however, there has been limited research focused on the unique barriers to OT access outside of metropolitan centres. In Queensland (QLD), Australia, OT is largely community‐based, with dosing, prescription and supply all occurring outside hospital settings. The state's vast size and regional spread create unique access challenges, especially given jurisdictional differences in prescriber regulations across Australia. The present study aimed to identify barriers to OT access in rural QLD. Methods: This study employed semi‐structured interviews with 12 participants, including five clinicians working in the OT and seven consumers residing in rural QLD who were currently receiving OT for OUD. Transcripts were analysed thematically. Results: Four themes were identified that articulate the primary barriers to OT: (i) restrictive dosing practices; (ii) stigma and social perceptions; (iii) overstretched access; and (iv) gaps in continuity and personalisation of care. Discussion and Conclusions: Rurality shapes treatment access not only through geographic isolation and limited infrastructure, but also through regulatory inconsistencies across regions, restricted service flexibility and the heightened visibility of individuals within small communities. These insights underscore the need for more localised, equity‐focused policy responses and further research into new alternative interventions, such as telehealth and strategies to enhance the acceptance and uptake of long‐acting injectable buprenorphine. [ABSTRACT FROM AUTHOR]
Copyright of Drug & Alcohol Review is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Psychology and Behavioral Sciences Collection
Description
Abstract:Introduction: Opioid treatment (OT) is highly effective for managing opioid use disorder (OUD) but remains underutilised worldwide, including in Australia. This issue is especially pronounced in regional and rural areas; however, there has been limited research focused on the unique barriers to OT access outside of metropolitan centres. In Queensland (QLD), Australia, OT is largely community‐based, with dosing, prescription and supply all occurring outside hospital settings. The state's vast size and regional spread create unique access challenges, especially given jurisdictional differences in prescriber regulations across Australia. The present study aimed to identify barriers to OT access in rural QLD. Methods: This study employed semi‐structured interviews with 12 participants, including five clinicians working in the OT and seven consumers residing in rural QLD who were currently receiving OT for OUD. Transcripts were analysed thematically. Results: Four themes were identified that articulate the primary barriers to OT: (i) restrictive dosing practices; (ii) stigma and social perceptions; (iii) overstretched access; and (iv) gaps in continuity and personalisation of care. Discussion and Conclusions: Rurality shapes treatment access not only through geographic isolation and limited infrastructure, but also through regulatory inconsistencies across regions, restricted service flexibility and the heightened visibility of individuals within small communities. These insights underscore the need for more localised, equity‐focused policy responses and further research into new alternative interventions, such as telehealth and strategies to enhance the acceptance and uptake of long‐acting injectable buprenorphine. [ABSTRACT FROM AUTHOR]
ISSN:09595236
DOI:10.1111/dar.70074